Biomedical research helps develop safe and effective disease treatments for all citizens. The 21st Century Cures Act, signed into law in December 2016, includes $4.8 billion to fund research and drug development. The law includes funds for the “Cancer Moonshot,” which seeks to accelerate cancer research in the United States. Cancer researchers at HCI urge the community to continue to support biomedical research.
"cancer moonshot" News
Mary Beckerle, PhD, CEO of Huntsman Cancer Institute, served as a panelist at an event organized by the White House Cancer Moonshot Task Force. Beckerle participated in a discussion on addressing disparities in access to cancer prevention, diagnosis, and treatment.
On September 7, 2016, National Cancer Institute (NCI) Acting Director Douglas Lowy, MD, accepted the recommendations of the Cancer Moonshot Blue Ribbon Panel (BRP) on a set of scientific approaches to accelerate progress in cancer research. An overview of the report was published in the journal Science.
Huntsman Cancer Institute (HCI) at the University of Utah participated in a national summit on the Cancer Moonshot initiative on June 29, 2016. The Cancer Moonshot Summits were organized at the request of Vice President Joe Biden, and more than 270 organizations hosted summits that brought together patients and survivors, researchers, physicians, advocates, philanthropists, and data and technology experts to brainstorm ways of speeding up progress in cancer prevention, diagnosis, treatment, and care over the next five years—and to ultimately end cancer as we know it.
The Cancer Moonshot Initiative, launched during President Barack Obama’s 2016 State of the Union address and headed by Vice President Joe Biden, is generating excitement and hope in the world of cancer research and care. Huntsman Cancer Institute at the University of Utah is playing an important role in these efforts.